Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 10.95
+0.45 (4.29%)
Aug 17, 2026, 4:02 PM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 45.68 million as of August 17, 2026. Its market cap has increased by 94.42% in one year.
Market Cap
45.68M
Enterprise Value
42.92M
Revenue
9.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.95
ChartMarket Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 45.68M, a decrease of -54.75%. That is a compound annual growth rate of -13.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 45.68M | 64.70% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| Creo Medical Group | 55.69M |
| Kooth | 53.50M |
| Shield Therapeutics | 46.54M |
| hVIVO | 45.00M |